Is levofloxacin-based triple therapy an alternative for first-line eradication of Helicobacter pylori? A systematic review and meta-analysis

By Xiao Shu-Ping   Gu Min   Zhang Guo-Xin  

Scandinavian Journal of Gastroenterology, Vol. 49, Iss. 5, 2014-05 ,pp. : 528-538

Informa Healthcare

Access to resources Recommend Favorite

Bismuth-Based First-Line Therapy for Helicobacter pylori Eradication in Type 2 Diabetes Mellitus Patients

By  

Digestion, Vol. 82, Iss. 1, 2010-03 ,pp. : 47-53

Karger

Access to resources Recommend Favorite

Comparison of Levofloxacin- and Moxifloxacin-Based Triple Therapies with Standard Treatment in Eradication of Helicobacter Pylori as First-Line Therapy

By  

Digestion, Vol. 90, Iss. 4, 2014-12 ,pp. : 261-264

Karger

Access to resources Recommend Favorite

Safety and efficacy of 1-week levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori -related peptic ulcer disease in Kashmir, India

By Shah Altaf  

Indian Journal of Gastroenterology, Vol. 32, Iss. 1, 2013-01 ,pp. : 32-36

Springer Publishing Company

Access to resources Recommend Favorite

Third-Line Rescue Therapy with Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (with Clarithromycin and Levofloxacin) for H. pylori Infection

By Gisbert J.   Perez-Aisa A.   Rodrigo L.   Molina-Infante J.   Modolell I.   Bermejo F.   Castro-Fernández M.   Antón R.   Sacristán B.   Cosme A.   Barrio J.   Harb Y.   Gonzalez-Barcenas M.   Fernandez-Bermejo M.   Algaba A.   Marín A.   McNicholl A.  

Digestive Diseases and Sciences, Vol. 59, Iss. 2, 2014-02 ,pp. : 383-389

Springer Publishing Company

Access to resources Recommend Favorite